PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced that it entered into a securities purchase agreement with new and existing investors for the issuance and sale of approximately 1,333,333 shares of its common stock…
PREDATOR protein engineering technology allows for the expansion of INDUKINE™ molecules beyond oncology targets into new applications across a range of immunology targets, including inflammatory bowel disease PREDATOR protein engineering technology allows for the expansion of INDUKINE™ molecules beyond oncology targets into new applications across a range of immunology targets, including inflammatory bowel disease Werewolf…
Das National Institute for Health and Care Research (NIHR), Innovate UK, das Advanced Therapy Treatment Centre Network und das Cell and Gene Therapy Catapult (CGT Catapult) haben eine strategische Initiative im Wert von fast 18 Millionen Pfund angekündigt. Ihr 17,9-Millionen-Pfund-Investitionsprogramm soll das britische Umfeld für klinische Studien zu Arzneimitteln für neuartige Therapien (ATMP) verbessern und…
Two anti-inflammatory molecules reduce the inflammatory response within the injured heart and reduce scarring, according to new research published in The American Journal of Pathology. Research into the protective effects of two anti-inflammatory molecules, transforming growth factor-beta1 (TGF?1) and Heligmosomoides polygyrus TGM (HpTGM), following heart attack found that both proteins reduced the inflammatory response within…
Das Institut für Radiologie im Klinikum Frankfurt (Oder) wurde zum Jahresbeginn neu strukturiert und in zwei Bereiche aufgeteilt. Prof. Dr. med. Jazan Omari, Experte für bildgeführte Tumortherapien, wechselte vom Universitätsklinikum Magdeburg ins Klinikum Frankfurt (Oder), und verantwortet nun als Chefarzt den Ausbau der Diagnostischen und Interventionellen Radiologie. Der Bereich der Neuroradiologie wird weiterhin von Chefarzt…
CDL Nuclear Technologies launched its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer. This cutting-edge mobile solution is designed to revolutionize cardiac care by directly providing state-of-the-art cardiac PET/CT imaging services to medical facilities on their schedule. Positioned as a low-risk, high-value option, the Mobile Cardiac PET/CT Trailer is aimed at enhancing cardiac programs across…
Die Ungleichheit auf dem Arbeitsmarkt zwischen Frauen und Männern ist in Deutschland am höchsten, wenn Kinder im Spiel sind. Das zeigen Auswertungen einer internationalen Forschungsgruppe, die die Entwicklung der Ungleichheit in 17 Ländern in Europa und Nordamerika über die vergangenen 50 Jahre untersucht hat. Unter den 30-Jährigen verdienen Mütter demnach im Durchschnitt 70 bis 80…
Ad hoc-Mitteilung gemäss Art. 53 KR Basilea gibt Erhalt der US-FDA-Zulassung für Antibiotikum ZEVTERA® (Ceftobiprol-Medocaril) für drei Indikationen bekannt
GLASGOW, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) — EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced that the Company has completed its £27m ($34m USD) funding round, supported by new and existing investors. The funding will be used to advance EBX’s lead product candidate, EBX-102-02 through a…
Planegg/Martinsried, April 4, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today announced that the Company has been issued a patent by the European Patent Office protecting its inducible Medigene T cell receptor (iM-TCR) technology, which contains a…
